Evidence map›Paper›PMID 39445764›Full record

ArticleJournal of cardiovascular electrophysiology2025

Prevalence of frequent premature ventricular contractions and left-ventricular systolic dysfunction in patients receiving Holter monitoring.

Juan Torrado, Adam Sima, Connor Comstuck, Karoly Kaszala, Alex Tan, Jayanthi Koneru, David S Frankel, Frank Marchlinski, Marcin Kowalski, Parikshit Sharma and 7 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03228823 (Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03228823 phase4unknown statusnot on this map

Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot Study

TypeinterventionalSponsorHunter Holmes Mcguire Veteran Affairs Medical CenterRan2018 to 2021Enrolled5ConditionsVentricular Premature Beats, Contractions, or Systoles, CardiomyopathiesArmsRadiofrequency ablation, Amiodarone (Antiarrhythmic drug)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Juan TorradoCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.ORCID 0000-0002-6527-4219
Adam SimaCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.
Connor ComstuckCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.
Karoly KaszalaCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.
Alex TanCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.
Jayanthi KoneruCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.ORCID 0000-0002-3586-0962
David S FrankelCardiology Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-9276-4857
Frank MarchlinskiCardiology Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-7962-9423
Marcin KowalskiCardiology Division, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.ORCID 0000-0003-3433-3711
Parikshit SharmaCardiology Division, Rush University Medical Center, Chicago, Illinois, USA.
Edward P GerstenfeldCardiology Division, UCSF Medical Center, San Francisco, California, USA.ORCID 0000-0002-7200-3521
Marmar VaseghiCardiology Division, UCLA Medical Center, Los Angeles, California, USA.
Kalyanam ShivkumarCardiology Division, UCLA Medical Center, Los Angeles, California, USA.
Rohit MalhotraCardiology Division, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Carlos MorilloLibin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
Kenneth A EllenbogenCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.ORCID 0000-0002-8527-569X
Jose F HuizarCardiology Division, Virginia Commonwealth University/Pauley Heart Center, Richmond, Virginia, USA.ORCID 0000-0002-5073-9765

Funding

Ventricular arrhythmias and mechanisms of parasympathetic dysfunction following myocardial infarctionR01HL148190 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VASEGHI, MARMAR · 2020 to 2024
$3.2M
Sex differences in cardiac autonomic remodeling after myocardial infarctionR01HL170626 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Crystal May Ripplinger, Marmar Vaseghi · 2024 to 2026
$2.1M
Mechanistic Insights of Premature Ventricular Contractions-induced CardiomyopathyR01HL139874 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI HUIZAR, JOSE FRANCISCO · 2018 to 2020
$2.0M
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS): A Pilot StudyR34HL138110 · NHLBI · RICHMOND INSTITUTE FOR VETERANS RESEARCH · PI DE MARCO, TERESA, ELLENBOGEN, KENNETH ALAN · 2017 to 2019
$601k
NHLBI NIH HHS R01 HL139874NHLBI NIH HHS R01 HL148190NHLBI NIH HHS R01 HL170626NHLBI NIH HHS R34 HL138110NIH HHS 1R01HL139874-01NIH HHS 1R34HL138110-01
6 · The paper itself

Abstract

backgroundPremature ventricular contractions (PVCs) are frequently observed with left ventricular (LV) systolic dysfunction, although the prevalence of these associated conditions in the general population remains unknown.

objectiveWe sought to understand the prevalence of frequent PVCs (defined PVCs > 5%) and high burden PVCs (defined PVCs > 10%) and LV systolic dysfunction in patients receiving ambulatory Holter monitors (HM).

methodsA prospective multicenter (eight US medical centers) cross-sectional study collected demographic and PVC burden data from consecutive patients undergoing 24-h, 48-h, and 14-day HM (July 2018-June 2020). Left ventricle ejection fraction (LVEF) data was collected if obtained within 6 months of HM. Four PVC burden groups were analyzed (<1%, 1%-5%, 5.1%-10%, and >10% burden) and stratified by normal LVEF (≥50%) or presence LVEF < 50%.

resultsThe prevalence of PVC burden of 5.1%-10% and >10% was 4% and 5%, respectively in the population undergoing HM (n = 6529). Age was significantly different between PVC groups (p < .001). In those with LVEF assessment (n = 3713), the prevalence of LVEF < 50% and both LVEF < 50% and PVC > 5% was 16.4% and 4.2%, respectively. The prevalence of PVC > 5% and PVC > 10% in patients with LVEF < 50% was 26% and 16%, respectively. PVC > 5% were more prevalent in older, male, and Caucasians (p < .001). Females had a lower prevalence of PVC > 5% than males (6% vs. 11%; p < .001), but not among those with LVEF < 50% (24% vs. 26%, p = .10).

conclusionPVC > 5% and PVC > 10% and LVEF < 50% are prevalent in patients undergoing HM. PVC > 5% are associated with older age. Females have a lower prevalence of PVC > 5% than males but similar combined PVC > 5% and LVEF < 50%. CLINICALTRIAL: gov identifier: NCT03228823.

Indexed as

Electrocardiography, AmbulatoryHeart RateVentricular Dysfunction, LeftVentricular Function, LeftVentricular Premature ComplexesAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPredictive Value of TestsPrevalenceProspective StudiesRisk FactorsStroke Volumeambulatory ECG monitoringcardiomyopathyheart failurepremature ventricular contractionssex differences

Identifiers

PMID39445764
PMCPMC11727014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.